Lootsma-Miklosova E, Aalders J G, Willemse P H, de Bruijn H W
Eur J Obstet Gynecol Reprod Biol. 1987 Mar;24(3):231-5. doi: 10.1016/0028-2243(87)90022-0.
Our study reports 6 patients with advanced adenocarcinoma of the fallopian tube, with elevated levels of serum CA 125 (greater than 35 U/ml). In two patients the serum CA 125 values were followed during treatment. In one of them the CA 125 values decreased during clinical remission and increased at the time of tumor progression. In the second patient we observed increasing levels of CA 125 preceding clinical evidence of recurrent disease. The possible usefulness of CA 125 for monitoring patients with tubal cancer is discussed.
我们的研究报告了6例晚期输卵管腺癌患者,其血清CA 125水平升高(大于35 U/ml)。对其中2例患者在治疗期间监测了血清CA 125值。其中1例患者的CA 125值在临床缓解期下降,在肿瘤进展时升高。在第2例患者中,我们观察到在复发性疾病的临床证据出现之前CA 125水平升高。本文讨论了CA 125在监测输卵管癌患者方面的潜在用途。